FOUNDATION 2019

Founded in 2019, we aimed at providing “Process Development” support to the Bio-Pharma Industry and hand hold them to initiate the “Manufacturing Process”. We have provided upscale Bioprocess support to many.

During those times we realized the challenges of “Cleaning and Validation” and we found Single use platform was the best and the world was moving towards it.

PROBLEM STATEMENT

MISSION

We decided to go with our PM Modiji’s vision of MAKE IN INDIA and marched on to test our skills.The idea of TBC Life Science Private Limited was conceived, under which we planned to cater to Cell and Gene Therapy to help in treating Cancer patients, within an affordable cost. UniQTainerr, UniQSerum and UniQCulture will be subsidiaries that will form a part of this initiative. They will also be capable of generating their own revenue model for sustainability of the project at large.

We started partnering with local manufacturers and tried the product with our clients over couple of projects.

WE PARTNERED

WE ASSEMBLED

Meanwhile, we gathered from several market survey reports across the globe that this market was projected to grow from US$ 2.9 Billion in 2021 to UD$ 9.6 Billion in 2026. CAGR of 26.3%. The Asia Pacific market was to witness the Highest CAGR during the forecast period. We also found out that Indian vaccine manufacturers exports 24.65% of the world’s requirement to WHO, GAVI etc. Many of the N-1 Bulk is shipped in the 3D Single use bags.

Our close interaction with the below companies gave us a better picture about the future of these bags & Containers.

BEGINNING